Christopher Gill
Profiles

Christopher J. Gill, MD

Professor, Global Health - Boston University School of Public Health

617-358-2438
cgill@bu.edu
Crosstown Center - 370
View Full Profile at BUMC

Biography

Christopher Gill has an MD from the University of Massachusetts Medical School and an MS from Tufts-Sackler School of Graduate Biomedical Studies.Dr. Gill is an infectious disease specialist by training. From 2002-2008 he was a faculty member of the Department of Global Health at Boston University School of Public Health, engaged in a wide variety of clinical trials and investigations. His research interests have focused on child survival, and include diarrheal diseases, tuberculosis, pneumococcal and meningococcal disease, adherence to HIV medications, and neonatal survival. He was the principal investigator of the Lufwanyama Neonatal Survival Project in Northern Zambia (LUNESP), a prospective, cluster randomized and controlled effectiveness study designed to determine whether training traditional birth attendants to manage several common perinatal conditions could reduce neonatal mortality in the setting of a resource poor country with limited access to healthcare. The results demonstrated that training traditional birth attendants in neonatal resuscitation skills significantly reduces neonatal mortality by approximately 50%. From 2008-end of 2010 he was the Director of the Meningitis ACWY conjugate vaccine clinical trials group at Novartis Vaccines. There he was responsible for the design, implementation and analysis of Phase IIb, III and IV clinical trials in support of the vaccine, and played a key role in licensing this new vaccine in over 60 countries around the world, including the US. In 2011, he rejoined the faculty at the BU Center for Global Health and Development and the BU School of Public Health, working as the Director of the BUSPH Pharmaceuticals Program from 2011-15, teaching, mentoring, and conducting research in the areas of HIV medication adherence in China, advocacy around child mortality due to diarrhea and pneumonia, pertussis and RSV disease surveillance in Zambia, and capacity building of Vietnamese community health workers using SMS text messaging. Dr. Gill is the 2015 recipient of the Norman Scotch Award for excellence in teaching at Boston University School of Public Health, and the 2016 recipient of Boston University's Metcalf Cup and Prize. The Metcalf Cup and Prize is BU's highest teaching honor, and is awarded to one of BU's >3500 faculty across its 17 colleges and schools each year.

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research - Boston University

Education

  • University of Massachusetts Medical School, MD Field of Study: Medicine
  • Tufts University, MS Field of Study: Clinical Evaluation/Research
  • Tufts University, BS Field of Study: Biology

Websites

Classes Taught

  • SPHEH735

Publications

  • Published on 12/6/2022

    Gill CJ, Mwananyanda L, MacLeod WB, Kwenda G, Pieciak RC, Etter L, Bridges D, Chikoti C, Chirwa S, Chimoga C, Forman L, Katowa B, Lapidot R, Lungu J, Matoba J, Mwinga G, Mubemba B, Mupila Z, Muleya W, Mwenda M, Ngoma B, Nakazwe R, Nzara D, Pawlak N, Pemba L, Saasa N, Simulundu E, Yankonde B, Thea DM. What is the prevalence of COVID-19 detection by PCR among deceased individuals in Lusaka, Zambia? A postmortem surveillance study. BMJ Open. 2022 Dec 06; 12(12):e066763. PMID: 36600354.

     Read At: PubMed
  • Published on 12/1/2022

    Gill CJ, Mwananyanda LM, MacLeod W, Kwenda G, Pieciak R, Etter L, Bridges D, Chikoti C, Chirwa S, Chimoga C, Forman L, Katowa B, Lapidot R, Lungu J, Matoba J, Mwiinga G, Mubemba B, Mupila Z, Muleya W, Mgoma B, Nakazwe R, Nzara D, Pawlak N, Pemba L, Simulundu E, Yankonde B, Thea DM. Sustained high prevalence of COVID-19 deaths from a systematic post-mortem study in Lusaka, Zambia: one year later. What is the prevalence of COVID-19 detection by PCR among deceased individuals in Lusaka, Zambia? A postmortem surveillance study. BMJ Open. 2022.
  • Published on 11/15/2022

    Osei-Poku GK, Mwananyanda L, Elliot PA, MacLeod WB, Somwe SW, Pieciak RC, Gill CJ. Assessing infant sleep practices and other risk factors of SIDS in Zambia: a cross-sectional survey of mothers in Lusaka, Zambia. BMC Pediatr. 2022 Nov 15; 22(1):660. PMID: 36380292.

     Read At: PubMed
  • Published on 11/1/2022

    Osei-Poku GK, Mwananyanda L, Elliot PA, MacLeod WB, Somwe WS, Pieciak RC, Hamapa A, Gill CJ. Assessing infant sleep practices and other risk factors of SIDS in Zambia: A cross-sectional survey of mothers in Lusaka, Zambia. BMC Pediatrics. 2022.

     Read At: Custom
  • Published on 8/30/2022

    Sabin LL, Mesic A, Le BN, Halim N, Cao CTH, Bonawitz R, Nguyen HV, Larson A, Nguyen TTT, Le AN, Gill CJ. Costs and Cost-Effectiveness of mCME Version 2.0: An SMS-Based Continuing Medical Education Program for HIV Clinicians in Vietnam. Glob Health Sci Pract. 2022 08 30; 10(4). PMID: 36041848.

     Read At: PubMed
  • Published on 7/13/2022

    Hall SM, Landaverde L, Gill CJ, Yee GM, Sullivan M, Doucette-Stamm L, Landsberg H, Platt JT, White L, Hamer DH, Klapperich CM. Comparison of anterior nares CT values in asymptomatic and symptomatic individuals diagnosed with SARS-CoV-2 in a university screening program. PLoS One. 2022; 17(7):e0270694. PMID: 35830378.

     Read At: PubMed
  • Published on 7/1/2022

    Lora L. Sabin, Aldina Mesic, Bao Ngoc Le, Nafisa Halim, Chi Thi Hue Cao, Rachael Bonawitz, Ha Viet Nguyen, Anna Larson, Tam Thi Thanh Nguyen, Anh Ngoc Le and Gill CJ. Costs and Cost-Effectiveness of the mCME Project ‘version 2.0’: a randomized controlled trial of a SMS-based continuing medical education intervention among Vietnamese HIV clinicians. Global Health Science And Practice. 2022.

     Read At: Custom
  • Published on 5/19/2022

    Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, Pariente AB, Bardach D, Bassat Q, Casalegno JS, Chakhunashvili G, Crawford N, Danilenko D, Do LAH, Echavarria M, Gentile A, Gordon A, Heikkinen T, Huang QS, Jullien S, Krishnan A, Lopez EL, Markic J, Mira-Iglesias A, Moore HC, Moyes J, Mwananyanda L, Nokes DJ, Noordeen F, Obodai E, Palani N, Romero C, Salimi V, Satav A, Seo E, Shchomak Z, Singleton R, Stolyarov K, Stoszek SK, von Gottberg A, Wurzel D, Yoshida LM, Yung CF, Zar HJ, Nair H. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022 05 28; 399(10340):2047-2064. PMID: 35598608.

     Read At: PubMed
  • Published on 4/12/2022

    Lapidot R, Faits T, Ismail A, Allam M, Khumalo ZTH, MacLeod W, Kwenda G, Mupila Z, Nakazwe R, Johnson WE, Thea DM, Mwananyanda L, Gill CJ. Nasopharyngeal dysbiosis precedes the development of lower respiratory tract infections in young infants. Gates Open Access Journal. 2022.

     Read At: Custom
  • Published on 4/1/2022

    Lohman-Payne B, Koster J, Gabriel B, Chilengi R, Forman LS, Heeren T, Duffy CR, Herlihy J, Crimaldi S, Gill C, Chavuma R, Mwananyanda L, Thea DM. Persistent Immune Activation in Human Immunodeficiency Virus-Infected Pregnant Women Starting Combination Antiretroviral Therapy After Conception. J Infect Dis. 2022 Apr 01; 225(7):1162-1167. PMID: 33780543.

     Read At: PubMed

View 140 more publications:View Full Profile at BUMC

News & In the Media

View all profiles